|
Practical Issues in the Management of Dyslipidemia in Women
Nieca Goldberg, MD
LDL-C remains the primary target of lipid-lowering therapy, with HDL-C and triglycerides as
secondary targets.
Intrapartum Management of the Growth-restricted Fetus
Gary Ventolini, MD;
Melanie Glover, MD;
Ran Neiger, MD
Establishing appropriate antenatal fetal surveillance at diagnosis can minimize adverse outcomes.
BONUS Coding Box On Page 14
Optimizing Bone Health in Women With Systemic
Lupus Erythematosus
Chin Lee, MD;
Rosalind Ramsey-Goldman, MD, DrPH
A proactive approach to optimizing bone health in this population is essential.
Primary Care for
Female Cancer Survivors
Alison Amsterdam, MD
Guidelines for female cancer
survivors—whose risks are significantly different—remain controversial.
The Hematologist, the
Gynecologist, and the Patient With Menorrhagia: May the Circle Be Unbroken
Peter A. Kouides, MD
Emerging data show that many
menorrhagic women actually have an underlying bleeding disorder.
back
to top
Departments
Editorial
Firsts
Vivian M. Dickerson, MD
In the Pipeline/New Products
Menopause Matters
Vaginal Estrogen Therapy: The Question of Systemic Absorption
JoAnn V. Pinkerton, MD
Case Report
Hypereosinophilic Syndrome
Associated With Cervical
Squamous Cell Carcinoma
Anup Hazra, MD;
Richard Siderits, MD;
Janusz J. Godyn, MD
Contraception Corner
Suppressing Menstruation
With Extended Hormonal
Contraception
Barbara Clark, RN, MSN, MPH;
Alison Edelman, MD, MPH
Author Guidelines
What Your Patients Are Reading
CME Test
Patient Handout
What You Should Know About Extended-cycle Contraception
Folleto Informativo Para La Paciente
Lo que Usted debe Saber sobre la Anticoncepción de Ciclo Prolongado
Classified Advertisements
back
to top |
